LncRNA DANCR, lncRNA A1BG-AS1, and lncRNA HOTTIP were found to contribute to tumor progression by interacting with miR-216a-5p in breast cancer, hepatocellular carcinoma and prostate cancer respectively 23. This evidence concerns the gene A1BG and breast carcinoma.